Insider · CIK 0001380177
Ronald Richard
Files at EBS (Emergent BioSolutions Inc.). First filing Dec 9, 2025, latest Dec 9, 2025.
Ronald Richard files SEC Form 4 as director at EBS (Emergent BioSolutions Inc.). Since Dec 9, 2025, Ronald Richard has reported 0 open-market buys worth $0 and 1 open-market sell worth $263k, the latest filed on Dec 9, 2025.
A track record needs three past buys with six months of prices behind them; Ronald Richard has 0, so none is measured yet.
The newest scored trade: sold $263k of EBS on Dec 5, 2025, filed Dec 9, 2025, scored 18 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $263k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EBS: Emergent BioSolutions Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 18Weak | EBSsell Emergent BioSolutions Inc. | $263k 21,984 shares | -21% | +179% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 5, 2025 | EBS EMERGENT BIOSOLUTIONS INC. | 32,848 0.06% of outstanding | $392k | Dec 5, 2025 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | EBS Emergent BioSolutions Inc. | AGrant or award Common Stock | +25,344 | $0.00 | $0 | 123,761 | May 4, 2026 |
| Apr 30, 2026 | EBS Emergent BioSolutions Inc. | AGrant or award Stock Option (Right to Buy)derivative | +11,296 | $0.00 | $0 | 11,296 | May 4, 2026 |
| Dec 5, 2025 | EBS Emergent BioSolutions Inc. | SOpen-market sale Common Stock | -7,100 | $12.11 | $86k | 98,417 | Dec 9, 2025 |
| Dec 5, 2025 | EBS Emergent BioSolutions Inc. | MOption exercise Common Stock | +25,748 | $5.02 | $129k | 124,165 | Dec 9, 2025 |
| Dec 5, 2025 | EBS Emergent BioSolutions Inc. | FTax withholding Common Stock | -10,864 | $11.90 | $129k | 113,301 | Dec 9, 2025 |
| Dec 5, 2025 | EBS Emergent BioSolutions Inc. | SOpen-market sale Common Stock | -14,884 | $11.90 | $177k | 98,417 | Dec 9, 2025 |
| Dec 5, 2025 | EBS Emergent BioSolutions Inc. | MOption exercise Stock Option (Right to Buy)derivative | -25,748 | $0.00 | $0 | 0 | Dec 9, 2025 |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Common Stock | +34,403 | $0.00 | $0 | 105,517 | May 2, 2025 |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,824 | $0.00 | $0 | 41,572 | May 2, 2025 |
Questions about Ronald Richard
Answered from the filings on this page, as of the latest one.
Is Ronald Richard buying or selling?
In the last 12 months Ronald Richard reported 0 open-market buys worth $0 and 1 open-market sell worth $263k on SEC Form 4; the latest was sold $263k of EBS on Dec 5, 2025. Grants, option exercises and tax withholding are not counted.
How did Ronald Richard's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronald Richard has 0.
Where does Ronald Richard file Form 4?
Ronald Richard has filed Form 4 at EBS (Emergent BioSolutions Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.